Capabilities and Expertise
West Analytical Services Particle Lab partners with customers to develop methods for analyzing unique drug delivery or containment products as well as utilize existing West component-specific methods. The Particle Lab performs testing to support every phase of your drug product from compatibility studies through to commercialization and lifecycle management. With the ability to handle biosafety level 1 and 2 drug products, our ability to partner and design studies to meet your portfolio of drug products is extensive.
Particle characterization and identification capabilities:
- Optical Microscopy
- Fourier Transform Infrared Spectroscopy (FT-IR)
- Micro FT-IR Scanning Electron Microscopy (SEM)/Energy Dispersive X-ray Spectroscopy (EDS)
- Laser Induced Breakdown-Spectroscopy (LIBS)
Glass delamination remains a significant concern for the storage of biologics. This is especially the case for large molecule formulations with high pH levels. The Particle Lab can perform glass delamination testing using Differential Interference Contrast Microscopy (DICM) to determine if glass delamination has the potential to occur on selected glass. In addition, the Particle Lab has the capability to perform particle counting and sizing for sub-visible and visible particles using:
- Membrane Microscopy
- Light Microscopy Image Analysis (LM/IA)
- Light Obscuration (LO)
New and Novel Techniques
The FlowCam® 8100 (Yokogawa Fluid Imaging Technologies) is used for sub-visible particle analysis. The instrument captures digital images of particles suspended in liquid as they pass through a flow cell. Each individual particle captured in the field of view has over 40 morphological characteristics, which can be used to create image libraries for particle characterization. The instrument uses the 21 CFR Part 11 compliant software program VisualSpreadsheet® to process captured images and generate customizable reports containing particle count and size.
The FlowCam 8100 can be used to monitor particle levels in drug products and can be used as a complement to Light Obscuration (LO) analysis for early phase compatibility studies. It is especially convenient for biologics because of the small sample volume requirements - as little as 300 µL per sample analysis.
Understanding particle origin and being able to differentiate between intrinsic (related to manufacturing process), extrinsic (foreign to manufacturing process) and inherent (related to product) particles is critical to understanding the risks associated with particles in the formulation. The FlowCam, which enables particle characterization, allows for determination of particle type which can provide a deeper understanding of the particles that are present in drug products.
FlowCam® and VisualSpreadsheet® are registered trademarks of Fluid Imaging Technologies, Inc.
May 03, 2021
Featured in over
Magazines and Online Industry Resources in 2020